Safety, immunogenicity, and efficacy of a modified COVID-19 mRNA vaccine, SW-BIC-213, in healthy people aged 18 years and above: a phase 3 double-blinded, randomized, parallel controlled clinical trial in Lao PDR (Laos)
在老挝人民民主共和国（老挝）开展的一项 3 期双盲、随机、平行对照临床试验中，对 18 岁及以上健康人群进行的改良型 COVID-19 mRNA 疫苗 SW-BIC-213 的安全性、免疫原性和有效性研究
期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2023.102372
Fang, Yi; Li, Jing-Xin; Duangdany, Davone; Li, Yang; Guo, Xi-Lin; Phamisith, Chanthala; Yu, Bo; Shen, Ming-Yun; Luo, Bin; Wang, Yu-Zhu; Liu, Si-Jun; Zhao, Fan-Fan; Xu, Cong-Cong; Qiu, Xu-Hui; Yan, Rong; Gui, Yu-Zhou; Pei, Rong-Juan; Wang, Jie; Shen, Haifa; Guan, Wu-Xiang; Li, Hang-Wen; Mayxay, Mayfong
